Abstract
thrombocytopenic purpura or cardiovascular disease patients and from healthy subjects. MPswere also obtained from purified human blood cell subpopulations. Identification of plasminogen activators on MPs was performed by zymography and their capacity to generate plasmin by chromogenic assay. Results: Circulating MPs isolated from patientsgenerate a range of plasmin activity at their surface. This property was related to a variable content in uPA and/or tPA. Using distinct MP subpopulations derived from endothelial cells, platelets, leukocytes and erythrocytes, we demonstrated that plasmin is generated on endothelialand leukocytederived MPs, but is absent on MPs from platelet or erythrocyte origins. Leukocyte-derived MPs bear uPA and its receptor uPAR whereas endothelial-derived MPs carry tPA and tPA/inhibitor complexes. Comment: Endothelialand leukocyte-derivedMPs, bearing respectively tPA or uPA, support at least a part of fibrinolytic activity in the circulation that is modulated in pathological settings. This blood-borne fibrinolytic activity conveyed by MPs provides a more comprehensive view on the role of MPs in the haemostatic equilibrium and put forward the basis for a potential new biomarker.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.